Nuveen Asset Management, LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 152 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$5,500,546
-37.6%
658,748
-0.6%
0.00%
-33.3%
Q2 2023$8,818,286
+115671.1%
663,029
+0.8%
0.00%0.0%
Q1 2023$7,617
+32.1%
657,798
-6.7%
0.00%
+50.0%
Q4 2022$5,768
-99.9%
705,107
-19.2%
0.00%0.0%
Q3 2022$5,066,000
+29.8%
872,637
-1.2%
0.00%0.0%
Q2 2022$3,902,000
-63.3%
882,915
-17.5%
0.00%
-33.3%
Q1 2022$10,639,000
-55.7%
1,070,303
-8.7%
0.00%
-57.1%
Q4 2021$24,041,000
-34.6%
1,172,718
-6.1%
0.01%
-36.4%
Q3 2021$36,787,000
-17.7%
1,249,559
-14.7%
0.01%
-15.4%
Q2 2021$44,718,000
+20.0%
1,464,179
+30.9%
0.01%
+8.3%
Q1 2021$37,255,000
+71.4%
1,118,420
+19.0%
0.01%
+71.4%
Q4 2020$21,737,000
+232.5%
940,052
+41.9%
0.01%
+133.3%
Q3 2020$6,537,000
+237.8%
662,402
+18.1%
0.00%
+200.0%
Q2 2020$1,935,000
+10.4%
560,956
-2.1%
0.00%0.0%
Q1 2020$1,753,000
-38.4%
573,084
+3.5%
0.00%0.0%
Q4 2019$2,845,000
-0.5%
553,491
-0.1%
0.00%0.0%
Q3 2019$2,860,000
-12.8%
554,180
+2.3%
0.00%0.0%
Q2 2019$3,279,000541,8440.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q2 2019
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$218,331,90938.11%
ORACLE INVESTMENT MANAGEMENT INC 2,015,495$26,806,08419.75%
Decheng Capital Management III (Cayman), LLC 1,463,872$19,469,4986.11%
Iron Triangle Partners LP 2,400,000$31,920,0004.27%
Jackson Square Partners, LLC 8,517,624$113,284,3993.30%
BOURNE LENT ASSET MANAGEMENT INC 580,000$7,714,0002.69%
ARK Investment Management 26,634,620$354,240,4432.34%
ARDSLEY ADVISORY PARTNERS LP 906,000$12,049,8002.04%
Avidity Partners Management LP 4,337,400$57,687,4202.02%
Nikko Asset Management Americas, Inc. 13,649,948$181,271,3091.91%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders